HBV-related HCC has been associated with specific oncogenic genomic events, including TERT alterations (e.g., HBV DNA integration into the TERT promoter appears to promote telomerase overexpression and cell immortality) [8] and TP53 promoter repression (leading to reduced TP53 expression) [9]. This evidence concerns the gene TERT and hepatocellular carcinoma.